REVVITY, INC Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
REVVITY, INC (RVTY) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $2.48 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-02-24
- REVVITY, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2025 was $2.48M, a 74.51% decline from fiscal 2024.
- REVVITY, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2024 was $9.71M, a 7.15% increase from fiscal 2023.
- REVVITY, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2023 was $9.07M, a 8.01% decline from fiscal 2023.
- REVVITY, INC accounts receivable, allowance for credit loss, period increase (decrease) for fiscal 2023 was $9.86M, a 43.81% increase from fiscal 2022.
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month as first filed |
|---|---|---|
| 2025-12-28 | $2.48M 10-K · filed 2026-02-24 | |
| 2024-12-29 | $9.71M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $9.07M 10-K · filed 2026-02-24 | |
| 2023-01-01 | $9.86M 10-K · filed 2025-02-25 | |
| 2022-01-02 | $6.85M 10-K · filed 2024-02-27 | $8.15M 10-K · filed 2022-03-03 |
| 2021-01-03 | $10.29M 10-K · filed 2023-03-01 | $16.70M 10-K · filed 2022-03-03 |
| 2019-12-29 | $6.85M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |